Evidence map›Paper›PMID 23392769›Full record

ArticleMolecular and cellular biochemistry2013

Neutrophil elastase induces MUC5AC secretion via protease-activated receptor 2.

Jia Zhou, Juliy M Perelman, Victor P Kolosov, Xiangdong Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Dipeptidyl peptidase-1 inhibitors in bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  5. Article
  6. Exacerbations of bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  7. Biomarkers in bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  8. Review
  9. Review
  10. Flavonoids as inhibitors of human neutrophil elastase.Journal of enzyme inhibition and medicinal chemistry · 2021
    Review
  11. PAR-2-activated secretion by airway gland serous cells: role for CFTR and inhibition byAmerican journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Protease-activated receptor 2 activates airway apical membrane chloride permeability and increases ciliary beating.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Jia ZhouDivision of Respiratory Medicine, The Second Affiliated Hospital, Chongqing Medical University, Yuzhong District, Chongqing, China. joelle_zhou@163.com
Juliy M Perelman
Victor P Kolosov
Xiangdong Zhou
Dalian Medical University · CNAcademy of Medical Sciences · GBFar Eastern Scientific Centre of Physiology and Pathology of Respiration Russian Academy of Medical Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucus hypersecretion is a major manifestation in patients with chronic inflammatory airway diseases, and mucin5AC (MUC5AC) protein is a major component of airway mucus. Previous studies have demonstrated that neutrophil elastase (NE) stimulates the secretion of MUC5AC from airway epithelial cells, however, the mechanism is poorly understood. NE is a known ligand for protein active receptors (PARs), which have been confirmed to participate in releasing MUC5AC in the airways. However, the role of PARs in NE-induced MUC5AC secretion remains unclear. We demonstrated that airway goblet-like Calu-3 cells express PAR1, PAR2, and PAR3 with a predominant level of PAR2. NE can increase PAR2 expression and MUC5AC release. In our study, we showed that NE binding to PAR2 can increase the cytosolic calcium concentration and subsequently activate PKC, leading to MUC5AC secretion. In order to investigate the mechanism of increased cytosolic calcium in Calu-3 cells, thapsigargin was used to exhaust the endoplasmic reticulum (ER) calcium pools, and 2-aminoethoxydiphenyl borate was used to inhibit the function of the store-operated calcium entry (SOCE) channels in the plasma membrane. We found that the NE-induced increase in intracellular calcium concentration is derived from release of the ER calcium pool and its subsequent calcium internal flux from the extracellular space via SOCE channels, which is dependent on sufficient levels of extracellular calcium.

Indexed as

BenzophenanthridinesBoron CompoundsCalcium Channel BlockersCalcium SignalingCell Line, TumorCell MembraneChelating AgentsCytoplasmEgtazic AcidEnzyme ActivationEnzyme InhibitorsGene ExpressionGene Expression RegulationHumansLeukocyte ElastaseMucin 5AC1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid1-3-methylbutyryl-N4-6-aminohexanoyl-piperazine2-aminoethoxydiphenyl borateBenzophenanthridinesBoron CompoundsCalcium Channel BlockersChelating AgentschelerythrineEgtazic AcidEnzyme InhibitorsLeukocyte ElastaseMUC5AC protein, humanMucin 5ACPiperazinesProtein Kinase CReceptor, PAR-2RNA, MessengerThapsigargin

Identifiers

PMID23392769
OpenAlexW2074186133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.